BRIEF published on 03/19/2026 at 15:05, 3 hours 52 minutes ago Accor Addresses Allegations on Human Rights Practices Accor Investigation Human Trafficking Human Rights Jeffrey Epstein
REGULATED PRESS RELEASE published on 03/19/2026 at 15:00, 3 hours 57 minutes ago Statement Accor Accor responds to report questioning human rights practices, denies involvement in trafficking, conducting internal investigation, emphasizes fight against human trafficking and exploitation of children, clarifies alleged links with Jeffrey Epstein Accor Jeffrey Epstein Human Rights Practices Trafficking Internal Investigation
BRIEF published on 03/03/2026 at 10:02, 16 days 8 hours ago Accor Discloses Share Capital and Voting Rights Voting Rights French Commercial Code Accor Shares Outstanding February 2026
REGULATED PRESS RELEASE published on 03/03/2026 at 09:57, 16 days 9 hours ago Disclosure of shares outstanding and voting rights - 03.03.2026 Accor discloses its share capital and voting rights as of February 28, 2026. Visit group.accor.com/en for more information Share Capital Voting Rights French Commercial Code Accor Disclosure
BRIEF published on 02/19/2026 at 07:35, 1 month ago Accor's 2025 Financial Performance Surpasses Expectations Revenue Growth Share Buyback Hospitality Sector Hotel Expansion Accor Financial Results
REGULATED PRESS RELEASE published on 02/19/2026 at 07:30, 1 month ago Full-Year 2025 Results: Solid results above 2025 guidance Accor reports solid full-year 2025 results, exceeding guidance. Strong performance driven by revPAR, net unit growth, and recurring EBITDA growth. Chairman Bazin emphasizes medium-term growth ambitions Accor Full-year Results RévPAR Net Unit Growth Recurring EBITDA
BRIEF published on 02/05/2026 at 11:35, 1 month 14 days ago Accor Announces Share Capital and Voting Rights Details Share Capital Voting Rights Accor Investor Information 2026 Disclosure
REGULATED PRESS RELEASE published on 02/05/2026 at 11:30, 1 month 14 days ago Disclosure of shares outstanding and voting rights - 05.02.2026 Accor releases regulated information disclosing share capital and voting rights. Visit https://group.accor.com/en for more details Share Capital Voting Rights Accor Regulated Information
BRIEF published on 01/22/2026 at 17:45, 1 month 28 days ago Accor Announces Share Capital and Voting Rights Update Voting Rights Accor Transparency Shares Outstanding 2025 Financial Update
REGULATED PRESS RELEASE published on 01/22/2026 at 17:40, 1 month 28 days ago Disclosure of shares outstanding and voting rights - 22.01.2026 Accor discloses share capital and voting rights information in accordance with Article L.233-8 II of the French Commercial Code Share Capital Voting Rights French Commercial Code Accor Disclosure
Published on 03/19/2026 at 14:20, 4 hours 37 minutes ago CBMJ CEO Rips Legacy Liberal Media Over Iran Coverage on The Schaftlein Report
Published on 03/19/2026 at 13:50, 5 hours 7 minutes ago Predictiv AI Appoints Multi-Agent Systems Pioneer Professor George Rzevski as Strategic Advisor to Advance Swarm AI Platforms
Published on 03/19/2026 at 13:30, 5 hours 27 minutes ago Hillcrest Energy Technologies CEO Don Currie Discusses ZVS Technology and Commercialization Progress in Stocks To Watch Investor Interview
Published on 03/19/2026 at 13:30, 5 hours 27 minutes ago ACCESS Newswire Reports Fourth Quarter and Full Year 2025 Results
Published on 03/19/2026 at 13:15, 5 hours 42 minutes ago Worksport Presents New Premium "Game Changer" Tonneau Cover Model to Industry Buyers at Keystone BIG Show; Initiates Pre-Orders Ahead of Near-Term Commercial Launch
Published on 03/19/2026 at 18:18, 39 minutes ago VINCORION SE successfully completes Initial Public Offering
Published on 03/19/2026 at 17:45, 1 hour 12 minutes ago mobilezone strengthens market position through the acquisition of Swiss e‑commerce platform Apfelkiste.ch and retail branding specialist MAREIN
Published on 03/19/2026 at 08:45, 10 hours 12 minutes ago Deezer and Sonos renew and expand long-term collaboration
Published on 03/19/2026 at 07:00, 11 hours 57 minutes ago bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
Published on 03/19/2026 at 07:00, 11 hours 57 minutes ago 2025 Annual results and new strategic signature
